Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Demethylphencynonate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100341850C details a novel chiral resolution method for demethylphencynonate salts, enabling >98% optical purity for anti-motion sickness API manufacturing with reduced costs.